• J Coll Physicians Surg Pak · Jan 2025

    The Role of 418 Gut Microbiota in Small Cell Lung Cancer Progression: A Mendelian Randomisation Study.

    • Rui Gong and Haiyang Li.
    • Department of Paediatrics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
    • J Coll Physicians Surg Pak. 2025 Jan 1; 35 (1): 606560-65.

    ObjectiveTo investigate the causal influence of gut microbiota on small cell lung cancer (SCLC) progression using Mendelian randomisation (MR), providing insights into the gut-lung axis in lung cancer pathology.Study DesignAnalytical study. Place and Duration of the Study: Department of Radiotherapy, Binhai County People's Hospital, Yancheng, Jiangsu, China, and Department of Paediatrics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China, from January to May 2024.MethodologyThe study used 18,340 single nucleotide polymorphisms (SNPs) as instrumental variables to analyse 418 gut microbiota varieties. The inverse variance weighted (IVW) and MR Egger's methods were applied to explore causal relationships. Sensitivity analyses, including leave-one-out tests and Cochrane's Q tests, ensured robust results. A uni-directional Mendelian randomisation (MR) analysis was conducted using summary statistics from genome-wide association studies (GWAS) provided by the MiBio-Gen and Finn-Gen consortia.ResultsMR identified several bacterial taxonomic groups significantly associated with SCLC risk. Protective factors included Bacteroidetes (p = 0.0154), Eubacterium ruminantium group (p = 0.0241), Barnesiella (p = 0.0015), Clostridia (p = 0.0242), Christensenellaceae (p = 0.0314), Ruminococcaceae UCG-003 (p = 0.0381), and an unknown genus in the Ruminococcaceae family (p = 0.0458). Conversely, the risk factors linked to increased SCLC risk included Firmicutes (p = 0.0456), Pasteurellaceae (p = 0.0177), Eubacterium oxidoreducens group (p = 0.0188), Pasteurellales (p = 0.0177), and Alcaligenaceae (p = 0.0423).ConclusionThe study suggests a protective role of specific gut microbiota against SCLC and identifies others that may increase the risk. The absence of heterogeneity and pleiotropy supports the causal associations, underscoring the significance of the gut-lung axis in SCLC and the utility of MR in cancer epidemiology.Key WordsSmall cell lung cancer, Gut microbiota, Mendelian randomisation, Causal inference, Cancer epidemiology.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…